Member Info for DaProphet

Ndn71..
But the question was focused on the mologic test when colin replied.

The question was asked about the new mologic test being produced and sold under there visitect brand . Colin replied the test would not be made to fulfill the DHSC contract but would be made available to third party customers..
Does that mean its a one horse race now for us?

I bet your a RMS holder who's still not forgiven trevor brown....
Go suck on a lemon

How odd.. Would never of expected a 40% rise on brh rns. And i dont think they did realising at that time of day. Glad i still kept a few shares..
They have 5 products in there arsenal that look interesting. Alzheimer’s & bladder cancer tests being a snippet. Due out in august i believe..
I imagine records will be broke when avacta releases the news on CV hopefully before 7th april.

Booooooooooom!
Shaka lakka!

My broker asking for money owed which they debited on my account for 100k shares(£2700) But nothing but the 8% is showing.. And there still asking for the full amount... The cheak of it...

Quidity
Have you had your shares authorised yet on ii?
Mine has not been fully clarified. Just says 100k shares minus £2700 on my account. No reference as yet..

Congratulations on those who applied for extra shares.. My question is what was the point in the sub 1/30 shares originally offered?
If the new value is 1/1 shares..

Was until Irene turned up.....
All's we need now is harry back tomorrow morning to seal our fate....

What was blubbering boris saying today every adult needs to test twice a week to stop another lockdown in the future?
Thats around 60million a week or there abouts in the uk... 240m a month.. I think ODX are goona have there hands full.....

Business will be booming soon. People fret far to much. The foundations are laid.. Easy investment to be in.. My hair has stopped falling out now.
Odx won't be able to deliver enough test when the sales start.. i imagine more expansion is needed long term.. Don't think ive ever looked forward to an april as much in my life.. As this one

Okehurst1..the avacta clinical evaluation was carried out at 2 sites uk&EU.. Which included 30 postive samples and 26 negative samples. The reason for the delay so far as explained in a recent RNS is "Porton Down used artificial samples and did not use clinical samples"
My gut feeling is avacta will be chosen on completion of CV. but Mologic could be used if this fails until rectified. Why else would avacta be associated with so many manufacturers /odx/GAD/bbi/abdx if this wasn't the case. And surely mologic would have already be named the one if it wasn't the case.
Regards ODX & Avacta lover

The timing of the closing of the Bookbuild, pricing and allocations are at the absolute discretion of the Bookrunner, in consultation with Cenkos, and the Company.



The Placing Shares, when issued, will be credited as fully paid and will rank pari passu in all respects with each other, with the Open Offer Shares and with the Existing Ordinary Shares, including, without limitation, the right to receive all dividends and other distributions declared, made or paid after the date of issue.

I don't like the idea of loading up money on my account if there's no actual evidence of a sale..
Just saying.. If it does provide to eligible. I will gladly sell some shares elsewhere to fund these..

Cupacoffee..
My case is the exactly the same as yours.. 100k
But i didn't have funds in my account although ii are saying the accounts been debited & in the red I'm led to believe its just a normal provisional procedure thats taken on these allocation of shares.
Question is, How long do we have to purchase these shares when more details are published on the 23rd?

Was his name ebenezer scrooge?

Stay off the crack pipe!

Another good question to ask is why can a company like medusa19(boohoo)
Quote on producing 50million test a month.
When ODX can only manufacture 10million tests a month? Are ODX manufacturing for mudusa19?

Yep.. The way i see it is nothings final until the moneys out of your bank account.. I can't see the broker subbing you funds to buy these shares..
My account says £2700 in the red.. But i take it's just a provisional amount until qfi have clarified what I'm entitled too then I imagine the broker will ask for funds before purchasing...

Paraytec’s grant funded project (AD Scanner) to deploy its ActiPix™ technology in the field of Alzheimer’s disease (AD) diagnosis, working with a pan-European consortium of Karolinska Institute, Biomotif, Vrije University Medical Centre Amsterdam and MS Vision, is making good progress. The project is on target to complete in August 2021 and aims to produce and test the first instrument for the prognosis of Alzheimer’s Disease by fast and simple blood test. The automated AD Scanner prototype with fully tested software is now in use. The instrument uses capillary isoelectric focusing (cIEF), together with ActiPix™technology, to identify the level of protein biomarkers (abnormal proteoforms) in blood samples. If present, these abnormal proteoforms are indicative of the likely rate of mental decline for a given AD patient. This is important because such information could be used by clinicians in early diagnosis to differentiate AD patients from those with mild cognitive impairment, and also by researchers to help develop better drugs to counter this devastating disease. Research conducted by the Alzheimer’s Society shows that, in 2019, there were over 850,000 people with dementia in the UK. The Society considers that more than 520,000 people in the UK have dementia caused by Alzheimer’s disease and this figure is set to rise